Increasing Coverage and Efficiency of Measles, Mumps, and Rubella Vaccine and Introducing Universal Varicella Vaccination in Europe: A Role for the Combined Vaccine
@article{Vesikari2007IncreasingCA, title={Increasing Coverage and Efficiency of Measles, Mumps, and Rubella Vaccine and Introducing Universal Varicella Vaccination in Europe: A Role for the Combined Vaccine}, author={T. Vesikari and C. Sadzot-Delvaux and B. Rentier and A. Gershon}, journal={The Pediatric Infectious Disease Journal}, year={2007}, volume={26}, pages={632-638} }
Universal mass vaccination according to a 2-dose measles-mumps-rubella (MMR) vaccine schedule is recommended by the World Health Organization and is fundamental to the control of these important diseases. Very high coverage (first dose, ≥95%; second dose, ≥80%) is necessary to achieve and sustain high population immunity, and eventually interrupt indigenous transmission of these diseases. In 2006, the Advisory Committee on Immunization Practices issued a recommendation for 2 doses of varicella… CONTINUE READING
Topics from this paper
48 Citations
Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
- Medicine
- Vaccine
- 2009
- 27
Vaccines for measles, mumps, rubella, and varicella in children.
- Medicine
- The Cochrane database of systematic reviews
- 2020
- 15
Measles–Mumps–Rubella–Varicella Combination Vaccine (ProQuad®): A Guide to Its Use in Children in the EU
- Medicine
- Pediatric Drugs
- 2015
- 2
Immunogenicity and safety of combined measles-mumps-rubella-varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore
- Medicine
- Human vaccines & immunotherapeutics
- 2013
- 6
Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine: an open-labeled, randomized trial in healthy Korean children
- Medicine
- Clinical and experimental vaccine research
- 2014
- 7
New combination vaccines: integration into pediatric practice.
- Medicine
- The Pediatric infectious disease journal
- 2007
- 3
References
SHOWING 1-10 OF 124 REFERENCES
Immunogenicity and Safety of Two Doses of Tetravalent Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children
- Medicine
- The Pediatric infectious disease journal
- 2006
- 98
Evaluation of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children
- Medicine
- The Pediatric infectious disease journal
- 2005
- 115
Immunogenicity and Safety of a Second Dose of Measles–Mumps–Rubella–Varicella Vaccine in Healthy Children Aged 5 to 6 Years
- Medicine
- The Pediatric infectious disease journal
- 2007
- 42
Safety and Immunogenicity of Early Vaccination with Two Doses of Tetravalent Measles-Mumps-Rubella-Varicella (MMRV) Vaccine in Healthy Children from 9 Months of Age
- Medicine
- Infection
- 2007
- 50
Evaluation of Live Attenuated Varicella Vaccine (Oka‐RIT Strain) and Combined Varicella and MMR Vaccination in 13–17‐Month‐Old Children
- Medicine
- Acta paediatrica Scandinavica
- 1991
- 24
Interruption of measles transmission in Gipuzkoa (Basque Country), Spain.
- Medicine
- Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
- 2004
- 3
Consensus: Varicella Vaccination of Healthy Children: A Challenge for Europe
- Medicine
- The Pediatric infectious disease journal
- 2004
- 91